Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.54 -0.43 (-0.98%)
As of: Sep 30, 2026 · 12:57 PM EDT

Supernus Pharmaceuticals, Inc. (SUPN) Operating Income (2011 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) reported Operating Income of -$57.96 million for Q2 2026, compared with $12.14 million a year earlier.

Analysis

Supernus Pharmaceuticals, Inc. (SUPN) Operating Income (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' Operating Income came in at -$109.99 million; for FY2025, it was -$62.28 million.

  • By year, Operating Income came in at $81.67 million in FY2024, -$5.27 million in FY2023, $46.12 million in FY2022 (-46.4%) and $86.03 million in FY2021 (-50.5%).
  • Five-year quarterly Operating Income spans a low of -$60.23 million in Q3 2025 and a high of $40.85 million in Q3 2024.
  • The high point for year-over-year Operating Income in five years was Q4 2022 (growth of 463.0%); the low point was Q4 2021 (a decline of 85.8%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.96 Mn
Dec 31, 2025 -3.94 Mn
Sep 30, 2025 -60.23 Mn
Jun 30, 2025 12.14 Mn
Mar 31, 2025 -10.26 Mn
Dec 31, 2024 21.41 Mn
Sep 30, 2024 40.85 Mn
Jun 30, 2024 22.57 Mn
Mar 31, 2024 -3.15 Mn
Dec 31, 2023 -996,000.00
Sep 30, 2023 8.14 Mn
Jun 30, 2023 -17.59 Mn
Mar 31, 2023 5.18 Mn
Dec 31, 2022 34.33 Mn
Sep 30, 2022 -1.52 Mn
Jun 30, 2022 11.35 Mn
Mar 31, 2022 1.97 Mn
Dec 31, 2021 6.10 Mn
Sep 30, 2021 32.60 Mn
Jun 30, 2021 34.11 Mn
API Access

Supernus Pharmaceuticals, Inc. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=SUPN&period=max&api_key=YOUR_API_KEY